Abstract:Since their inception, genome-wide association studies (GWAS) have identified more than a hundred thousand single nucleotide polymorphism (SNP) loci that are associated with various complex human diseases or traits. The majority of GWAS discoveries are located in non-coding regions of the human genome and have unknown functions. The valley between non-coding GWAS discoveries and downstream affected genes hinders the investigation of complex disease mechanism and the utilization of human genetics for the improvement of clinical care. Meanwhile, advances in high-throughput sequencing technologies reveal important genomic regulatory roles that non-coding regions play in the transcriptional activities of genes. In this review, we focus on data integrative bioinformatics methods that combine GWAS with functional genomics knowledge to identify genetically regulated genes. We categorize and describe two types of data integrative methods. First, we describe fine-mapping methods. Fine-mapping is an exploratory approach that calibrates likely causal variants underneath GWAS signals. Fine-mapping methods connect GWAS signals to potentially causal genes through statistical methods and/or functional annotations. Second, we discuss gene-prioritization methods. These are hypothesis generating approaches that evaluate whether genetic variants regulate genes via certain genetic regulatory mechanisms to influence complex traits, including colocalization, mendelian randomization, and the transcriptome-wide association study (TWAS). TWAS is a gene-based association approach that investigates associations between genetically regulated gene expression and complex diseases or traits. TWAS has gained popularity over the years due to its ability to reduce multiple testing burden in comparison to other variant-based analytic approaches. Multiple types of TWAS methods have been developed with varied methodological designs and biological hypotheses over the past 5 years. We dive into discussions of how TWAS methods differ in many aspects and the challenges that different TWAS methods face. Overall, TWAS is a powerful tool for identifying complex trait-associated genes. With the advent of single-cell sequencing, chromosome conformation capture, gene editing technologies, and multiplexing reporter assays, we are expecting a more comprehensive understanding of genomic regulation and genetically regulated genes underlying complex human diseases and traits in the future.

Understanding the Function of Regulatory DNA Interactions in the Interpretation of Non-Coding GWAS Variants

Exploring the mechanisms of genome-wide long-range interactions: interpreting chromosome organization.

How chromatin interactions shed light on interpreting non-coding genomic variants: opportunities and future direc-tions

Non-coding genetic variants in human disease

Exploring noncoding variants in genetic diseases: From detection to functional insights

A New Approach for Discovering Functional Links Connecting Non-Coding Regulatory Variants to Gene Targets

From GWAS to Gene: Transcriptome-Wide Association Studies and Other Methods to Functionally Understand GWAS Discoveries

Understanding Regulatory Mechanisms of Brain Function and Disease Through 3D Genome Organization

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Genetic Study of Complex Diseases in the Post-GWAS Era

Translation of genome-wide association study: from genomic signals to biological insights

Unravelling the world of cis -regulatory elements

Decoding polygenic diseases: advances in noncoding variant prioritization and validation

From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases

GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits

Complexities of Understanding Function from CKD-Associated DNA Variants

3D Genome and Its Disorganization in Diseases

Three-dimensional genome architecture and emerging technologies: looping in disease

Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation

Genomic annotation of disease-associated variants reveals shared functional contexts

Dissecting Regulatory Mechanisms Underlying Noncoding GWAS SNPs on 20 Autoimmune Disease